Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dediulia, Tatjana"'
Autor:
Cepeda, Edgar B., Dediulia, Tatjana, Fernando, Joan, Bertran, Esther, Egea, Gustavo, Navarro, Estanislao, Fabregat, Isabel
Publikováno v:
In BBA - Molecular Cell Research May 2015 1853(5):1205-1218
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dediulia, Tatjana
Hepatocellular carcinoma (HCC) is a complex disease with a poor prognosis which has increased the survival rates on account to the improvement in patient stratification and the introduction of new targeted therapies. However, there is still an urgent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::410657d13f65c290fe18d80f1e8652c0
Autor:
Dropmann, Anne, Dooley, Steven, Dewidar, Bedair, Hammad, Seddik, Dediulia, Tatjana, Werle, Julia, Hartwig, Vanessa, Ghafoory, Shahrouz, Woelfl, Stefan, Korhonen, Hanna, Janicot, Michel, Wosikowski, Katja, Itzel, Timo, Teufel, Andreas, Schuppan, Detlef, Stojanovic, Ana, Cerwenka, Adelheid, Nittka, Stefanie, Piiper, Albrecht, Gaiser, Timo
Publikováno v:
Gut; Sep2020, Vol. 69 Issue 9, p1677-190, 14p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dropmann A; Molecular Hepatology, Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany., Dediulia T; Molecular Hepatology, Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany., Breitkopf-Heinlein K; Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany., Korhonen H; Isarna Therapeutics GmbH, Munich, Germany., Janicot M; Isarna Therapeutics GmbH, Munich, Germany., Weber SN; Department of Medicine II, Saarland University Medical Center, Homburg, Germany., Thomas M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Piiper A; Medizinische Klinik 1, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany., Bertran E; Bellvitge Biomedical Research Institute (IDIBELL) and University of Barcelona L'Hospitalet, Barcelona, Spain., Fabregat I; Bellvitge Biomedical Research Institute (IDIBELL) and University of Barcelona L'Hospitalet, Barcelona, Spain., Abshagen K; Institute for Experimental Surgery, Rostock University Medical Center, Rostock, Germany., Hess J; Research Group Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Section Experimental and Translational Head and Neck Oncology, Department of Otolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany., Angel P; Division of Signal Transduction and Growth Control, DKFZ-ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany., Coulouarn C; Institut National de la Santé et de la Recherche Médicale UMR991, University of Rennes, Pontchaillou University Hospital, Rennes, France., Dooley S; Molecular Hepatology, Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany., Meindl-Beinker NM; Molecular Hepatology, Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
Publikováno v:
Oncotarget [Oncotarget] 2016 Apr 12; Vol. 7 (15), pp. 19499-518.